174 related articles for article (PubMed ID: 12521076)
1. Evaluation of post-plan dosimetry using TRUS and CT after transperineal prostate seed implant.
Helmick R; Tarver R; Chan R; Caldwell S
Med Dosim; 2002; 27(4):289-93. PubMed ID: 12521076
[TBL] [Abstract][Full Text] [Related]
2. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
Bowes D; Crook JM; Araujo C; Batchelar D
Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
[TBL] [Abstract][Full Text] [Related]
4. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
Crook J; McLean M; Yeung I; Williams T; Lockwood G
Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
[TBL] [Abstract][Full Text] [Related]
5. Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy.
Tisseverasinghe S; Marbán M; Crook J; Petrik D; Araujo C
Brachytherapy; 2021; 20(4):849-856. PubMed ID: 33867295
[TBL] [Abstract][Full Text] [Related]
6. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
Haworth A; Ebert M; St Clair S; Carey BM; Flynn A; Bottomley DM; Duchesne GM; Joseph D; Ash D
Brachytherapy; 2005; 4(2):146-53. PubMed ID: 15893269
[TBL] [Abstract][Full Text] [Related]
7. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy.
Igidbashian L; Donath D; Carrier JF; Lassalle S; Hervieux Y; David S; Bahary JP; Taussky D
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):605-9. PubMed ID: 18793964
[TBL] [Abstract][Full Text] [Related]
8. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.
Lee WR; deGuzman AF; Bare RL; Marshall MG; McCullough DL
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):83-8. PubMed ID: 10656377
[TBL] [Abstract][Full Text] [Related]
9. Live implant dosimetry may be an effective replacement for postimplant computed tomography in localized prostate cancer patients receiving low dose rate brachytherapy.
Roshan D; Joyce K; Woulfe P; Gorakati PR; Stock R; Sullivan FJ
Brachytherapy; 2021; 20(4):873-882. PubMed ID: 33840634
[TBL] [Abstract][Full Text] [Related]
10. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the feasibility of using transrectal ultrasound for postimplant dosimetry in low-dose-rate prostate brachytherapy.
Davies RS; Perrett T; Powell J; Barber J; Tanguay J; Button M; Cochlin D; Smith C; Lester JF
Med Dosim; 2016 Winter; 41(4):290-295. PubMed ID: 27623391
[TBL] [Abstract][Full Text] [Related]
12. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
[TBL] [Abstract][Full Text] [Related]
13. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
[TBL] [Abstract][Full Text] [Related]
14. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
16. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
[TBL] [Abstract][Full Text] [Related]
17. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy.
Solhjem MC; Davis BJ; Pisansky TM; Wilson TM; Mynderse LA; Herman MG; King BF; Geyer SM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):767-76. PubMed ID: 15465193
[TBL] [Abstract][Full Text] [Related]
18. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
[TBL] [Abstract][Full Text] [Related]
19. Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants.
Narayana V; Roberson PL; Winfield RJ; McLaughlin PW
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):341-6. PubMed ID: 9308937
[TBL] [Abstract][Full Text] [Related]
20. Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours.
Golshan M; Mahdavi SS; Samei G; Lobo J; Pickles T; James Morris W; Keyes M; Peacock M; Salcudean SE; Spadinger I
Brachytherapy; 2020; 19(5):589-598. PubMed ID: 32682777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]